In addition, significant improvement was demonstrated in the Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog) scores in subjects who were non-carriers of APOE4 [APOE4(−)] compared to those who were carriers [APOE4(+)]. The gene discussed is APOE; the disease is Alzheimer disease.